These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14979239)

  • 21. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying widely covered drugs and drug coverage variation among Medicare part D formularies.
    Tseng CW; Mangione CM; Brook RH; Keeler E; Dudley RA
    JAMA; 2007 Jun; 297(23):2596-602. PubMed ID: 17579228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare prescription drugs: making the new program work.
    Jaffe J
    EBRI Issue Brief; 2004 Jun; (270):1-14. PubMed ID: 15218820
    [No Abstract]   [Full Text] [Related]  

  • 26. Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.
    Paterson JM; Laupacis A; Bassett K; Anderson GM;
    Health Aff (Millwood); 2006; 25(5):1436-43. PubMed ID: 16966744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of incentive-based formularies on drug utilization and spending.
    Sandy LG; Heady T
    N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 15002122
    [No Abstract]   [Full Text] [Related]  

  • 29. Prescription-drug coverage for medicare beneficiaries.
    Iglehart JK
    N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of incentive-based formularies on drug utilization and spending.
    Shrank WH
    N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 14999122
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
    N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should Medicare adopt the Veterans Health Administration formulary?
    Frakt AB; Pizer SD; Feldman R
    Health Econ; 2012 May; 21(5):485-95. PubMed ID: 21506191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
    Romley JA; Sanchez Y; Penrod JR; Goldman DP
    Health Aff (Millwood); 2012 Apr; 31(4):683-90. PubMed ID: 22492884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits and consequences for the poor and the disabled.
    Elliott RA; Majumdar SR; Gillick MR; Soumerai SB
    N Engl J Med; 2005 Dec; 353(26):2739-41. PubMed ID: 16382058
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost not the primary factor driving drug coverage.
    Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 37. CMS: Medicare drug formularies to cover most HIV drugs.
    AIDS Policy Law; 2005 Aug; 20(15):2. PubMed ID: 16136681
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 39. Location strongest factor in getting ADAP help.
    AIDS Alert; 2001 May; 16(5):57-8, 53. PubMed ID: 11590779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consumers face higher costs as health plans seek to control drug spending.
    Mays GP; Hurley RE; Grossman JM
    Issue Brief Cent Stud Health Syst Change; 2001 Nov; (45):1-4. PubMed ID: 11865903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.